Steven M Chan

14PUBLICATIONS
100CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 23, 2026
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, Is Effective in Acute Myeloid Leukemia Preclinical Models.

|Feb 14, 2026
Blood-based epigenetic instability linked to human aging and disease.

Salman Basrai, Ido Nofech-Mozes, Rajesh Detroja

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Apr 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis.

Kira A Young, Mohsen Hosseini, Jayna J Mistry

|Apr 16, 2025
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

|Mar 11, 2025
TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling.

Yitong Yang, Severine Cathelin, Alex C H Liu

Pageof 3

Frequent Collaborators

5 joint publications

Aaron D Schimmer

3 joint publications

Mohsen Hosseini

3 joint publications

Jennifer J Trowbridge

3 joint publications

Mark D Minden